In an effort to identify new PCa biomarkers in liquid biopsies, we recently established that semen levels of sTWEAK were lower in high-risk patients than in low-risk peers and that this reduction was accompanied by a trend for an increase in the Fn14 mRNA expression levels in seminal cell sediment [16]. The gene discussed is TNFRSF12A; the disease is posterior cortical atrophy.